Instant NanoBiosensors Co Ltd
- Medical device or technology
- Other products or services
- Synthesis, analytic, diagnostic services
- Digital health
- Biotech or pharma, animal health
- Biotech – food & agriculture
- Other R&D services
Instant NanoBiosensors (INB) is a cutting-edge precision medicine company. We develop and commercialize two distinct technology platforms: one for ultra-sensitive protein-based blood testing targeting Alzheimer’s disease, and another for advanced gene-based leukemia diagnostics through our proprietary INLab NGS Solution.
- Alzheimer's Diagnostic Platform: For early, ultra-sensitive detection of Alzheimer’s disease. The platform seamlessly integrates from antibody screening to ultra-sensitive assay development
- Leukemia Embedded Precision Medicine- INLab NGS Solution: An NGS-based platform offering personalized treatment options. We offers integrated solutions that combine automated NGS instruments, reagents, and software analysis, simplifying the entire process from sample collection to report generation.
In addition to its headquarters in Taiwan, Instant NanoBiosensors has a subsidiary in the Netherlands, strengthening its commitment to global collaboration and innovation.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}